Leica Optical Coherence Tomography (OCT) systems support ophthalmologists, ophthalmic surgeons, and researchers with easy-to-use, high-quality imaging technology. The preclinical OCT solutions provide insight into eye disease research, while the clinical OCT systems serve as an aid in diagnosing pathological conditions. Each system is non-invasive, contact-free, and helps detect and monitor morphological changes of ocular tissue.
OCT from Leica Microsystems
With the acquisition of Bioptigen in 2015, Leica Microsystems offers OCT imaging systems for clinical ophthalmology and preclinical research.
Perioperative OCT provides anatomic feedback to the surgeon, which aids in the visualization of physiological and pathological conditions during ophthalmic surgery, and helps guide surgical decision making in anterior as well as posterior cases.
Bioptigen’s OCT systems have revolutionized the clinical practice of ophthalmology by providing high-resolution images, ultra-fast scanning, and deep insight into anatomic information. It has become the gold standard imaging modality for many conditions for aiding in the diagnosis and monitoring of therapeutic outcomes, and has quickly become one of the most frequently ordered diagnostic tests in all of medicine. The Envisu C2300 is the world’s only handheld FDA-cleared OCT system for aiding in the diagnosis of eye disease.
Research OCT imaging systems support small to large animal eye research through high-quality, rapid, and contact-free image acquisition.